Clinical Trial Update: Voriconazole and Caspofungin Acetate in Treating Invasive Fungal Infections in Patients With Weakened Immune Systems [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating voriconazole plus caspofungin acetate for invasive fungal infections in immunocompromised adults; the study was terminated and results …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Invasive Fungal Infection

Drugs mentioned

• Cancidas (caspofungin)
• VFEND (Voriconazole)

Snippet

Sponsor: OHSU Knight Cancer Institute | Conditions: Infection, Unspecified Adult Solid Tumor, Protocol Specific | Phase 2 | Status: TERMINATED | Results posted: 2011-12-09